NUVECTIS PHARMA INC(NASDAQ:NVCT) stock News

NVCT Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Announces the Initiation of the Phase 1b Program for NXP900

11 days ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Announces the Initiation of the Phase 1b Program for NXP900

17 days ago - By: The Motley Fool

Nuvectis (NVCT) Q2 Loss Widens 43%

18 days ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

22 days ago - By: Benzinga - Mentions: PBM ALGN DYAI SNGX ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

23 days ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Provides Final Clinical Data Update from the NXP800 Phase 1b Study in Ovarian Cancer and Reports Completion of the NXP900 Phase 1a Dose Escalation Study

23 days ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Provides Final Clinical Data Update from the NXP800 Phase 1b Study in Ovarian Cancer and Reports Completion of the NXP900 Phase 1a Dose Escalation Study

2 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies

3 months ago - By: Benzinga - Mentions: RGC WORX PRTA STIM ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

3 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference

3 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference

4 months ago - By: Zacks Investment Research

Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect?

4 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

4 months ago - By: Yahoo Finance - Mentions: DERM PFE DHI CMG ...

Why Nuvectis Pharma, Inc. (NVCT) is Surging in 2025

4 months ago - By: Yahoo Finance - Mentions: DERM CMRX MNPR MASS

Why Journey Medical Corporation (DERM) is Surging in 2025

4 months ago - By: Yahoo Finance - Mentions: VZ DERM DHI CMG

Americans saved money in fintechs. When money went missing, FDIC was no where to be found

4 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting

4 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting

5 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting

5 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting

5 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma to Participate in the 37th Annual Roth Conference

5 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma to Participate in the 37th Annual Roth Conference

6 months ago - By: Market News Alerts

Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation

6 months ago - By: Nuvectis Pharma, Inc.

Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC

6 months ago - By: Market News Alerts